Skip to main content
Back to main menu

About Us

How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more
Accountability

Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country
Featured Ebola Gaza Israel war Humanitarian aid cuts

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries
Featured Haiti Palestine Democratic Republic of Congo (DRC)

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
MSF Access

MSF Access pushes for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
MSF Science Portal

Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

GO TO SITE
Noma

Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

GO TO SITE
TIC

The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

GO TO SITE
Telemedicine

MSF's telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

GO TO SITE
Sweden Innovation Unit

Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

GO TO SITE
Geo MSF

The GeoMSF platform is a dynamic one-stop-shop website for all of MSF's GIS related services and products. Access maps and applications through the catalogue, request geographical support, or produce a map on GeoMSF.

GeoMSF
Ebola disease in DRC: find out how we're responding
Learn more
8009 Results
 
37-year-old Nyan Oo* started ART in December 2011. When tested, his CD4 level was 34. Because his family does not have the money to pay for accommodation in Yangon, he and his mother are staying in a local monastery while he receives his ART treatment. *name has been changed
Myanmar

Lives in the balance: The urgent need for HIV and TB treatment in Myanmar

In a report released today Médecins Sans Frontières (MSF), the largest provider of HIV treatment in Myanmar, highlights the critical need for increased HIV and Tuberculosis (TB), including multidrug-resistant tuberculosis (MDR-TB), treatment in the country. Report - 22 Feb 2012
 
Reception area in MSF Clinic C.
Access to medicines

MSF calls for urgent action to save lives in Myanmar

Between 15,000 and 20,000 people living with HIV die every year in Myanmar because of lack of access to lifesaving anti-retroviral therapy (ART). With political reform being reciprocated by greater engagement from the international community, there is a real opportunity to put access to treatment for people living with HIV and TB at the top of donor priority lists. Press Release - 22 Feb 2012
 
Maung Myint*, 38, is HIV positive and has a CD4 count of less than 200 below WHO criteria for enrollment on ART. Due to overwhelming numbers of patients, MSF is not yet able to start him on the lifesaving treatment. Maung Myint is receiving anti-TB treatment. *name has been changed
Myanmar

Lives in the Balance: the story of Maung Myint

Maung Myint*, 38, is HIV positive and has a CD4 count of less than 200 below WHO criteria for enrollment on ART. Voices from the Field - 21 Feb 2012
 
Somali refugees are settling the land at the edge of Dadaab refugee camp.
Kenya

Dadaab refugee camps: Back to square one

Médecins Sans Frontières (MSF) launches today a public communication called “Dadaab: Back to square one.” The international medical organisation takes stock of the current humanitarian situation and operational challenges in Dadaab, Kenya, home to the world’s largest refugee camp. The open report also reviews the emergency response MSF provided throughout 2011. Report - 16 Feb 2012
 
Lel Omar admitted in early October to the therapeutic feeding center at msf hospital in Dagahaley camp part of the sprawling refugee camp complex in Dadaab, Kenya. Lel's mother was also admitted to the hospital, leaving only his uncle to care for him. The family fled Kismayo in September 2011 for Dadaab.
Kenya

MSF launches new report: 'Dadaab: Back to square one'

MSF's new report entitled "Dadaab: Back to square one" takes stock of the current humanitarian situation and operational challenges in Dadaab, Kenya, home to the world’s largest refugee camp. The refugees in Dadaab – and others on their way – need more than ever the continuous support of the UNHCR, the Kenyan government and humanitarian organisations to be able to survive. Press Release - 16 Feb 2012
 
msf-placeholder
India

MSF launches new Novartis campaign

As the Indian Supreme Court readies to hear the Novartis case, MSF tells Novartis to STOP its attack on India, the pharmacy of the developing world. Project Update - 15 Feb 2012
 
msf-placeholder
India

About the Novartis Drop the Case campaign

In 2006 the drug company Novartis took the Indian government to court over its patent law, in a move that threatened access to affordable medicines produced in India for millions of people across the developing world. The company wanted to get the law changed so that they could more easily extend the patents on their products, and stop generic companies producing the same medicines at a fraction of the price. Project Update - 15 Feb 2012
 
msf-placeholder
India

Open letter from MSF President to Indian PM Manmohan Singh on FTA

Ahead of the India-Europe Summit on 10 February 2012, where a roadmap to conclude the EU-India free trade agreement (FTA) is set to be agreed, the international medical humanitarian organization Médecins Sans Frontières (MSF) would like to draw your attention to specific harmful provisions in the proposed intellectual property (IP) and investment chapters, that if included would have serious implications for access to affordable medicines in India and throughout the developing world. Project Update - 10 Feb 2012
 
msf-placeholder
India

EU-India trade deal could cut medicines lifeline for people in developing countries

As India and the European Union meet for a Summit in New Delhi today to iron out the differences over a Free Trade Agreement, nearly two thousand people living with HIV and MSF protested in the streets of the Indian capital to warn that remaining harmful provisions in the agreement could have a severely negative impact on access to affordable medicine for people in developing countries. Press Release - 10 Feb 2012
 
A family cleaning their house from the rubbles after being destroyed by the war. Al Mishlab, east of Raqqa city.
Syria

Video testimonies

These testimonies from injured people across Syria were collected by Médecins Sans Frontières (MSF) staff between 30 January and 6 February 2012. Voices from the Field - 8 Feb 2012
Four mothers posing in a corridor of the Hospital in Bili. All four of them are staying in the hospital with their child, that's suffering from a severe case of malaria. Since the beginning of the project in 2016, the pediatric ward already treated more than 4.000 cases of complicated/severe form of malaria.
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more